Opioid Release after High-Intensity Interval Training in Healthy Human Subjects

Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and concomitant effective changes affect central opioidergic responses is unknown. We studied the effects of acute physical exercise on the cerebr...

Full description

Saved in:
Bibliographic Details
Published inNeuropsychopharmacology (New York, N.Y.) Vol. 43; no. 2; pp. 246 - 254
Main Authors Saanijoki, Tiina, Tuominen, Lauri, Tuulari, Jetro J, Nummenmaa, Lauri, Arponen, Eveliina, Kalliokoski, Kari, Hirvonen, Jussi
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and concomitant effective changes affect central opioidergic responses is unknown. We studied the effects of acute physical exercise on the cerebral μ-opioid receptors (MOR) of 22 healthy recreationally active males using positron emission tomography (PET) and the MOR-selective radioligand [ C]carfentanil. MOR binding was measured in three conditions on separate days: after a 60-min aerobic moderate-intensity exercise session, after a high-intensity interval training (HIIT) session, and after rest. Mood was measured repeatedly throughout the experiment. HIIT significantly decreased MOR binding selectively in the frontolimbic regions involved in pain, reward, and emotional processing (thalamus, insula, orbitofrontal cortex, hippocampus, and anterior cingulate cortex). Decreased binding correlated with increased negative emotionality. Moderate-intensity exercise did not change MOR binding, although increased euphoria correlated with decreased receptor binding. These observations, consistent with endogenous opioid release, highlight the role of the μ-opioid system in mediating affective responses to high-intensity training as opposed to recreational moderate physical exercise.
AbstractList Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and concomitant effective changes affect central opioidergic responses is unknown. We studied the effects of acute physical exercise on the cerebral μ-opioid receptors (MOR) of 22 healthy recreationally active males using positron emission tomography (PET) and the MOR-selective radioligand [11C]carfentanil. MOR binding was measured in three conditions on separate days: after a 60-min aerobic moderate-intensity exercise session, after a high-intensity interval training (HIIT) session, and after rest. Mood was measured repeatedly throughout the experiment. HIIT significantly decreased MOR binding selectively in the frontolimbic regions involved in pain, reward, and emotional processing (thalamus, insula, orbitofrontal cortex, hippocampus, and anterior cingulate cortex). Decreased binding correlated with increased negative emotionality. Moderate-intensity exercise did not change MOR binding, although increased euphoria correlated with decreased receptor binding. These observations, consistent with endogenous opioid release, highlight the role of the μ-opioid system in mediating affective responses to high-intensity training as opposed to recreational moderate physical exercise.Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and concomitant effective changes affect central opioidergic responses is unknown. We studied the effects of acute physical exercise on the cerebral μ-opioid receptors (MOR) of 22 healthy recreationally active males using positron emission tomography (PET) and the MOR-selective radioligand [11C]carfentanil. MOR binding was measured in three conditions on separate days: after a 60-min aerobic moderate-intensity exercise session, after a high-intensity interval training (HIIT) session, and after rest. Mood was measured repeatedly throughout the experiment. HIIT significantly decreased MOR binding selectively in the frontolimbic regions involved in pain, reward, and emotional processing (thalamus, insula, orbitofrontal cortex, hippocampus, and anterior cingulate cortex). Decreased binding correlated with increased negative emotionality. Moderate-intensity exercise did not change MOR binding, although increased euphoria correlated with decreased receptor binding. These observations, consistent with endogenous opioid release, highlight the role of the μ-opioid system in mediating affective responses to high-intensity training as opposed to recreational moderate physical exercise.
Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and concomitant effective changes affect central opioidergic responses is unknown. We studied the effects of acute physical exercise on the cerebral μ-opioid receptors (MOR) of 22 healthy recreationally active males using positron emission tomography (PET) and the MOR-selective radioligand [ C]carfentanil. MOR binding was measured in three conditions on separate days: after a 60-min aerobic moderate-intensity exercise session, after a high-intensity interval training (HIIT) session, and after rest. Mood was measured repeatedly throughout the experiment. HIIT significantly decreased MOR binding selectively in the frontolimbic regions involved in pain, reward, and emotional processing (thalamus, insula, orbitofrontal cortex, hippocampus, and anterior cingulate cortex). Decreased binding correlated with increased negative emotionality. Moderate-intensity exercise did not change MOR binding, although increased euphoria correlated with decreased receptor binding. These observations, consistent with endogenous opioid release, highlight the role of the μ-opioid system in mediating affective responses to high-intensity training as opposed to recreational moderate physical exercise.
Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and concomitant effective changes affect central opioidergic responses is unknown. We studied the effects of acute physical exercise on the cerebral μ-opioid receptors (MOR) of 22 healthy recreationally active males using positron emission tomography (PET) and the MOR-selective radioligand [ 11 C]carfentanil. MOR binding was measured in three conditions on separate days: after a 60-min aerobic moderate-intensity exercise session, after a high-intensity interval training (HIIT) session, and after rest. Mood was measured repeatedly throughout the experiment. HIIT significantly decreased MOR binding selectively in the frontolimbic regions involved in pain, reward, and emotional processing (thalamus, insula, orbitofrontal cortex, hippocampus, and anterior cingulate cortex). Decreased binding correlated with increased negative emotionality. Moderate-intensity exercise did not change MOR binding, although increased euphoria correlated with decreased receptor binding. These observations, consistent with endogenous opioid release, highlight the role of the μ-opioid system in mediating affective responses to high-intensity training as opposed to recreational moderate physical exercise.
Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and concomitant effective changes affect central opioidergic responses is unknown. We studied the effects of acute physical exercise on the cerebral μ-opioid receptors (MOR) of 22 healthy recreationally active males using positron emission tomography (PET) and the MOR-selective radioligand [11 C]carfentanil. MOR binding was measured in three conditions on separate days: after a 60-min aerobic moderate-intensity exercise session, after a high-intensity interval training (HIIT) session, and after rest. Mood was measured repeatedly throughout the experiment. HIIT significantly decreased MOR binding selectively in the frontolimbic regions involved in pain, reward, and emotional processing (thalamus, insula, orbitofrontal cortex, hippocampus, and anterior cingulate cortex). Decreased binding correlated with increased negative emotionality. Moderate-intensity exercise did not change MOR binding, although increased euphoria correlated with decreased receptor binding. These observations, consistent with endogenous opioid release, highlight the role of the μ-opioid system in mediating affective responses to high-intensity training as opposed to recreational moderate physical exercise.
Author Tuominen, Lauri
Kalliokoski, Kari
Hirvonen, Jussi
Arponen, Eveliina
Tuulari, Jetro J
Nummenmaa, Lauri
Saanijoki, Tiina
Author_xml – sequence: 1
  givenname: Tiina
  surname: Saanijoki
  fullname: Saanijoki, Tiina
– sequence: 2
  givenname: Lauri
  surname: Tuominen
  fullname: Tuominen, Lauri
– sequence: 3
  givenname: Jetro J
  surname: Tuulari
  fullname: Tuulari, Jetro J
– sequence: 4
  givenname: Lauri
  orcidid: 0000-0002-2497-9757
  surname: Nummenmaa
  fullname: Nummenmaa, Lauri
– sequence: 5
  givenname: Eveliina
  surname: Arponen
  fullname: Arponen, Eveliina
– sequence: 6
  givenname: Kari
  surname: Kalliokoski
  fullname: Kalliokoski, Kari
– sequence: 7
  givenname: Jussi
  surname: Hirvonen
  fullname: Hirvonen, Jussi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28722022$$D View this record in MEDLINE/PubMed
BookMark eNptkc1r3DAQxUVJaTZpbz0XQS89xFt9W74UQmizgcBCm0JuQpbHu1q8sivJgf3vqyVJaUNPMzC_ebyZd4ZOwhgAofeULCnh-nOYpiUjtF5SoV-hBa0FqRQX9ydoQXTDK8r5_Sk6S2lHCJW10m_QKdM1Y4SxBVqvJz_6Dn-HAWwCbPsMEa_8ZlvdhAwh-XzAxy4-2AHfReuDDxvsA16BHfL2gFfz3gb8Y2534HJ6i173dkjw7qmeo5_fvt5drarb9fXN1eVt5QRluVJt03MLSjKqOqlcoxxhoEWreEdkD8J2UsiG1D0rXjWrieau7YVtHbEtc_wcfXnUneZ2D52DkKMdzBT93saDGa03_06C35rN-GBkzRqpSBH49CQQx18zpGz2PjkYBhtgnJOhDSO8EYKLgn58ge7GOYZyXqFqKbWSvCnUh78d_bHy_OsCsEfAxTGlCL1xPtvsx6NBPxhKzDFQUwI1x0BNCbQsXbxYetb9L_4bfX-iKQ
CitedBy_id crossref_primary_10_1038_s41386_019_0368_x
crossref_primary_10_1523_JNEUROSCI_2380_20_2020
crossref_primary_10_24193_cbb_2024_28_03
crossref_primary_10_13181_mji_oa_203569
crossref_primary_10_1002_hbm_24224
crossref_primary_10_1098_rstb_2019_0292
crossref_primary_10_1093_scan_nsz042
crossref_primary_10_1016_j_peptides_2020_170348
crossref_primary_10_3233_BPL_190081
crossref_primary_10_1016_j_neuroimage_2020_116922
crossref_primary_10_7717_peerj_11471
crossref_primary_10_1016_j_copsyc_2018_02_021
crossref_primary_10_1080_00222895_2021_1980366
crossref_primary_10_3389_fonc_2021_745280
crossref_primary_10_1016_j_psychsport_2023_102399
crossref_primary_10_1038_s41437_019_0282_3
crossref_primary_10_1177_19417381221075354
crossref_primary_10_1186_s10194_022_01503_y
crossref_primary_10_3390_antiox9050445
crossref_primary_10_1016_j_neubiorev_2020_05_005
crossref_primary_10_1097_j_pain_0000000000002165
crossref_primary_10_1021_acschemneuro_7b00489
crossref_primary_10_1016_j_lfs_2024_122799
crossref_primary_10_1186_s40798_024_00718_4
crossref_primary_10_1089_imr_2022_0028
crossref_primary_10_4103_ijcfm_ijcfm_148_20
crossref_primary_10_1080_09593985_2024_2392183
crossref_primary_10_3389_fpsyg_2020_01296
crossref_primary_10_1038_s41398_024_02796_0
crossref_primary_10_1249_MSS_0000000000002895
crossref_primary_10_3389_fnimg_2024_1332384
crossref_primary_10_1007_s00431_025_06022_x
crossref_primary_10_1007_s11914_018_0461_9
crossref_primary_10_1007_s12035_023_03247_5
crossref_primary_10_31189_2165_6193_10_3_117
crossref_primary_10_1080_17437199_2020_1728564
crossref_primary_10_1371_journal_pone_0279468
crossref_primary_10_3390_cancers13020264
crossref_primary_10_3390_molecules24224190
crossref_primary_10_1016_j_jpsychires_2024_01_012
crossref_primary_10_1016_j_psyneuen_2021_105173
crossref_primary_10_33881_2011_7191_mct_15101
crossref_primary_10_3758_s13415_019_00710_6
crossref_primary_10_1038_s41386_020_0725_9
crossref_primary_10_1016_j_physbeh_2018_07_010
crossref_primary_10_1021_acs_jmedchem_2c01965
crossref_primary_10_3758_s13415_021_00960_3
crossref_primary_10_3389_fphys_2022_1093965
crossref_primary_10_1002_ejp_1508
crossref_primary_10_1155_2020_7905387
crossref_primary_10_1016_j_peh_2020_100158
crossref_primary_10_1002_ejp_4783
crossref_primary_10_1007_s10902_022_00528_z
crossref_primary_10_3390_molecules27092863
crossref_primary_10_1038_s41583_018_0028_x
crossref_primary_10_3389_fnhum_2022_997131
crossref_primary_10_1016_j_encep_2023_03_004
crossref_primary_10_3389_fpubh_2021_554291
crossref_primary_10_1080_02791072_2024_2311143
crossref_primary_10_1097_j_pain_0000000000001969
crossref_primary_10_3389_fpsyt_2023_1120230
crossref_primary_10_1186_s12986_021_00573_0
crossref_primary_10_1038_s41380_018_0107_4
crossref_primary_10_1007_s00520_020_05834_x
crossref_primary_10_3390_healthcare12212140
crossref_primary_10_1097_PHM_0000000000001705
crossref_primary_10_1155_2022_1764589
crossref_primary_10_14814_phy2_15831
crossref_primary_10_3389_fpsyg_2017_02176
crossref_primary_10_1155_prm_3432659
crossref_primary_10_56984_8ZG2EF824g
crossref_primary_10_1007_s10549_017_4571_3
crossref_primary_10_1249_MSS_0000000000002359
crossref_primary_10_1016_j_cobeha_2021_03_026
Cites_doi 10.1371/journal.pone.0114541
10.1073/pnas.0905307106
10.1136/bjsm.32.2.111
10.1348/135910702169358
10.1126/science.1060952
10.1523/JNEUROSCI.5492-10.2011
10.2165/00007256-199724010-00002
10.1093/cercor/bhn013
10.1093/cercor/bhv086
10.1055/s-0033-1347242
10.3389/fphar.2014.00116
10.1111/bph.13812
10.1249/MSS.0000000000000721
10.1007/s40279-015-0321-z
10.1002/hbm.21416
10.1123/jsep.32.2.253
10.1136/bjsports-2013-092576
10.1038/npp.2015.340
10.1073/pnas.0400266101
10.1016/j.brainresbull.2010.07.009
10.1055/s-0031-1287848
10.1136/bjsm.2004.011718
10.1017/S1461145714000704
10.2165/00007256-199213010-00003
10.1016/0005-7916(94)90063-9
10.1016/j.psychsport.2016.09.005
10.1152/japplphysiol.00521.2002
10.1073/pnas.1514996112
10.1111/jnc.12976
10.1006/nimg.1997.0303
10.1038/nrn2333
10.1002/syn.20404
10.1016/0014-2999(89)90582-7
10.3389/fpsyg.2015.01105
10.1016/S0969-8051(02)00411-0
10.1016/j.mhpa.2009.01.002
10.1016/0022-3999(95)00554-4
10.1037/0022-3514.54.6.1063
10.1073/pnas.102174799
10.1007/s40279-015-0365-0
10.1038/npp.2009.129
10.1249/mss.0b013e31806ad73c
10.1093/brain/awm255
10.1038/jcbfm.1989.59
10.1007/s00259-008-0935-6
10.1016/j.biopsych.2012.01.027
10.1016/j.neuropharm.2015.05.022
10.1080/02640414.2010.545427
10.1523/JNEUROSCI.22-12-05100.2002
ContentType Journal Article
Copyright Copyright Nature Publishing Group Jan 2018
Copyright © 2018 American College of Neuropsychopharmacology 2018 American College of Neuropsychopharmacology
Copyright_xml – notice: Copyright Nature Publishing Group Jan 2018
– notice: Copyright © 2018 American College of Neuropsychopharmacology 2018 American College of Neuropsychopharmacology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1038/npp.2017.148
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Psychology Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

ProQuest One Psychology
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Physical exercise and μ-opioid system
EISSN 1740-634X
EndPage 254
ExternalDocumentID PMC5729560
28722022
10_1038_npp_2017_148
Genre Journal Article
GroupedDBID ---
-DZ
-Q-
0R~
29N
2WC
36B
39C
4.4
406
5RE
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAYXX
AAYZH
ABAKF
ABBRH
ABDBE
ABFSG
ABIVO
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMFV
ACMJI
ACPRK
ACRQY
ACSTC
ACZOJ
ADBBV
ADFRT
AEFQL
AEJRE
AEMSY
AENEX
AESKC
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AOIJS
ASPBG
ATHPR
AVWKF
AYFIA
AZFZN
AZQEC
BAWUL
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
CS3
DIK
DNIVK
DPUIP
DWQXO
E3Z
EBLON
EBS
EE.
EIOEI
EJD
F5P
FDB
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GNUQQ
GX1
HCIFZ
HMCUK
HYE
HZ~
IWAJR
JSO
JZLTJ
KQ8
M1P
M2M
M7P
NQJWS
O9-
OK1
P2P
P6G
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RNT
RNTTT
ROL
RPM
SNX
SNYQT
SOHCF
SOJ
SRMVM
SWTZT
TAOOD
TBHMF
TDRGL
TR2
UKHRP
W2D
ZGI
--K
1B1
53G
5VS
AAEDT
AALRI
AAQFI
AAQXK
AAXUO
ABMAC
ABRTQ
ABWVN
ACIUM
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEUPX
AFPUW
AGQPQ
CAG
CGR
COF
CUY
CVF
ECM
EIF
EMB
EMOBN
FEDTE
FGOYB
HVGLF
IHE
LGEZI
LOTEE
M41
MK0
NADUK
NPM
NQ-
NXXTH
PJZUB
PPXIY
PQGLB
R2-
RIG
RNS
RPZ
SEW
SSZ
SV3
ZKB
3V.
7TK
7XB
8FE
8FH
8FK
K9.
LK8
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c412t-6b9f3ae65216d56c96c02e84b63d05fe4ad545907f2287827083cbf4abc0ab2c3
IEDL.DBID 7X7
ISSN 0893-133X
1740-634X
IngestDate Thu Aug 21 18:30:23 EDT 2025
Mon Jul 21 10:09:36 EDT 2025
Fri Jul 25 09:01:09 EDT 2025
Mon Jul 21 06:06:07 EDT 2025
Thu Apr 24 23:03:35 EDT 2025
Tue Jul 01 01:05:34 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c412t-6b9f3ae65216d56c96c02e84b63d05fe4ad545907f2287827083cbf4abc0ab2c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-2497-9757
OpenAccessLink https://www.nature.com/articles/npp2017148.pdf
PMID 28722022
PQID 1975586539
PQPubID 33935
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5729560
proquest_miscellaneous_1920394434
proquest_journals_1975586539
pubmed_primary_28722022
crossref_citationtrail_10_1038_npp_2017_148
crossref_primary_10_1038_npp_2017_148
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-01-01
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: New York
PublicationTitle Neuropsychopharmacology (New York, N.Y.)
PublicationTitleAlternate Neuropsychopharmacology
PublicationYear 2018
Publisher Nature Publishing Group
Publisher_xml – name: Nature Publishing Group
References Z Milanović (BFnpp2017148_CR34) 2015; 45
AH Goldfarb (BFnpp2017148_CR19) 1997; 24
J Hirvonen (BFnpp2017148_CR25) 2009; 36
L Schwarz (BFnpp2017148_CR42) 1992; 13
MAI Aberg (BFnpp2017148_CR2) 2009; 106
S Heijnen (BFnpp2017148_CR23) 2015; 6
CJ Endres (BFnpp2017148_CR16) 2003; 30
WP Morgan (BFnpp2017148_CR35) 1985; 17
Lauri Nummenmaa (BFnpp2017148_CR36) 2017; 175
P Wahl (BFnpp2017148_CR48) 2013; 45
EG Duerden (BFnpp2017148_CR14) 2013; 34
SN Haber (BFnpp2017148_CR21) 2010; 35
P Ekkekakis (BFnpp2017148_CR15) 2011; 41
MSR de Oliveira (BFnpp2017148_CR10) 2010; 83
JJ Frost (BFnpp2017148_CR17) 1989; 9
EE Hall (BFnpp2017148_CR22) 2002; 7
D Watson (BFnpp2017148_CR49) 1988; 54
I Mick (BFnpp2017148_CR33) 2014; 17
D Scully (BFnpp2017148_CR44) 1998; 32
M Titeler (BFnpp2017148_CR46) 1989; 167
BRR Oliveira (BFnpp2017148_CR37) 2015; 6
V Trezza (BFnpp2017148_CR47) 2011; 31
ES Decker (BFnpp2017148_CR11) 2017; 28
M Kilpatrick (BFnpp2017148_CR28) 2007; 39
EH Chartoff (BFnpp2017148_CR7) 2014; 5
GN Ruegsegger (BFnpp2017148_CR39) 2015; 97
AL Sgherza (BFnpp2017148_CR45) 2002; 93
J Fuss (BFnpp2017148_CR18) 2015; 112
G Henriksen (BFnpp2017148_CR24) 2008; 131
S Aaltonen (BFnpp2017148_CR1) 2012; 33
I Liberzon (BFnpp2017148_CR30) 2002; 99
A Colasanti (BFnpp2017148_CR8) 2012; 72
SJ Colcombe (BFnpp2017148_CR9) 2004; 101
H Boecker (BFnpp2017148_CR5) 2008; 18
RN Gunn (BFnpp2017148_CR20) 1997; 6
JK Zubieta (BFnpp2017148_CR53) 2001; 293
A Dietrich (BFnpp2017148_CR12) 2004; 38
KS Weston (BFnpp2017148_CR50) 2014; 48
JS Ramos (BFnpp2017148_CR38) 2015; 45
M Kanning (BFnpp2017148_CR27) 2010; 32
S Leknes (BFnpp2017148_CR29) 2008; 9
MM Bradley (BFnpp2017148_CR6) 1994; 25
ME Jung (BFnpp2017148_CR26) 2014; 9
RM Arida (BFnpp2017148_CR3) 2015; 132
JD Bartlett (BFnpp2017148_CR4) 2011; 29
DJ Scott (BFnpp2017148_CR43) 2007; 61
J-K Zubieta (BFnpp2017148_CR52) 2002; 22
RR Yeung (BFnpp2017148_CR51) 1996; 40
T Saanijoki (BFnpp2017148_CR40) 2015; 47
RK Dishman (BFnpp2017148_CR13) 2009; 2
C Mazzeschi (BFnpp2017148_CR31) 2014; 2014
H Saarimäki (BFnpp2017148_CR41) 2016; 26
I Mick (BFnpp2017148_CR32) 2016; 41
References_xml – volume: 9
  start-page: e114541
  year: 2014
  ident: BFnpp2017148_CR26
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0114541
– volume: 106
  start-page: 20906
  year: 2009
  ident: BFnpp2017148_CR2
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0905307106
– volume: 32
  start-page: 111
  year: 1998
  ident: BFnpp2017148_CR44
  publication-title: Br J Sports Med
  doi: 10.1136/bjsm.32.2.111
– volume: 7
  start-page: 47
  year: 2002
  ident: BFnpp2017148_CR22
  publication-title: Br J Health Psychol
  doi: 10.1348/135910702169358
– volume: 293
  start-page: 311
  year: 2001
  ident: BFnpp2017148_CR53
  publication-title: Science
  doi: 10.1126/science.1060952
– volume: 31
  start-page: 6362
  year: 2011
  ident: BFnpp2017148_CR47
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.5492-10.2011
– volume: 41
  start-page: 641
  year: 2011
  ident: BFnpp2017148_CR15
  publication-title: port Med
– volume: 24
  start-page: 8
  year: 1997
  ident: BFnpp2017148_CR19
  publication-title: Sports Med
  doi: 10.2165/00007256-199724010-00002
– volume: 18
  start-page: 2523
  year: 2008
  ident: BFnpp2017148_CR5
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/bhn013
– volume: 26
  start-page: 2563
  year: 2016
  ident: BFnpp2017148_CR41
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/bhv086
– volume: 45
  start-page: 827
  year: 2013
  ident: BFnpp2017148_CR48
  publication-title: Horm Metab Res
  doi: 10.1055/s-0033-1347242
– volume: 5
  start-page: 116
  year: 2014
  ident: BFnpp2017148_CR7
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2014.00116
– volume: 175
  start-page: 2737
  issue: 14
  year: 2017
  ident: BFnpp2017148_CR36
  publication-title: British Journal of Pharmacology
  doi: 10.1111/bph.13812
– volume: 47
  start-page: 2604
  year: 2015
  ident: BFnpp2017148_CR40
  publication-title: Med Sci Sports Exerc
  doi: 10.1249/MSS.0000000000000721
– volume: 45
  start-page: 679
  year: 2015
  ident: BFnpp2017148_CR38
  publication-title: Sports Med
  doi: 10.1007/s40279-015-0321-z
– volume: 34
  start-page: 109
  year: 2013
  ident: BFnpp2017148_CR14
  publication-title: Hum Brain Mapp
  doi: 10.1002/hbm.21416
– volume: 32
  start-page: 253
  year: 2010
  ident: BFnpp2017148_CR27
  publication-title: J Sport Exerc Psychol
  doi: 10.1123/jsep.32.2.253
– volume: 48
  start-page: 1227
  year: 2014
  ident: BFnpp2017148_CR50
  publication-title: Br J Sports Med
  doi: 10.1136/bjsports-2013-092576
– volume: 41
  start-page: 1742
  year: 2016
  ident: BFnpp2017148_CR32
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2015.340
– volume: 101
  start-page: 3316
  year: 2004
  ident: BFnpp2017148_CR9
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0400266101
– volume: 83
  start-page: 278
  year: 2010
  ident: BFnpp2017148_CR10
  publication-title: Brain Res Bull
  doi: 10.1016/j.brainresbull.2010.07.009
– volume: 33
  start-page: 157
  year: 2012
  ident: BFnpp2017148_CR1
  publication-title: Int J Sports Med
  doi: 10.1055/s-0031-1287848
– volume: 38
  start-page: 536
  year: 2004
  ident: BFnpp2017148_CR12
  publication-title: Br J Sports Med
  doi: 10.1136/bjsm.2004.011718
– volume: 17
  start-page: 2069
  year: 2014
  ident: BFnpp2017148_CR33
  publication-title: Int J Neuropsychopharmacol
  doi: 10.1017/S1461145714000704
– volume: 13
  start-page: 25
  year: 1992
  ident: BFnpp2017148_CR42
  publication-title: Sport Med
  doi: 10.2165/00007256-199213010-00003
– volume: 25
  start-page: 49
  year: 1994
  ident: BFnpp2017148_CR6
  publication-title: J Behav Ther Exp Psychiatry
  doi: 10.1016/0005-7916(94)90063-9
– volume: 28
  start-page: 1
  year: 2017
  ident: BFnpp2017148_CR11
  publication-title: Psychol Sport Exerc
  doi: 10.1016/j.psychsport.2016.09.005
– volume: 93
  start-page: 2023
  year: 2002
  ident: BFnpp2017148_CR45
  publication-title: J Appl Physiol
  doi: 10.1152/japplphysiol.00521.2002
– volume: 112
  start-page: 13105
  year: 2015
  ident: BFnpp2017148_CR18
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1514996112
– volume: 132
  start-page: 206
  year: 2015
  ident: BFnpp2017148_CR3
  publication-title: J Neurochem
  doi: 10.1111/jnc.12976
– volume: 6
  start-page: 279
  year: 1997
  ident: BFnpp2017148_CR20
  publication-title: Neuroimage
  doi: 10.1006/nimg.1997.0303
– volume: 2014
  start-page: 854129
  year: 2014
  ident: BFnpp2017148_CR31
  publication-title: Biomed Res Int
– volume: 9
  start-page: 314
  year: 2008
  ident: BFnpp2017148_CR29
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn2333
– volume: 61
  start-page: 707
  year: 2007
  ident: BFnpp2017148_CR43
  publication-title: Synapse
  doi: 10.1002/syn.20404
– volume: 167
  start-page: 221
  year: 1989
  ident: BFnpp2017148_CR46
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(89)90582-7
– volume: 6
  start-page: 1890
  year: 2015
  ident: BFnpp2017148_CR23
  publication-title: Front Psychol
– volume: 6
  start-page: 1105
  year: 2015
  ident: BFnpp2017148_CR37
  publication-title: Front Psychol
  doi: 10.3389/fpsyg.2015.01105
– volume: 30
  start-page: 177
  year: 2003
  ident: BFnpp2017148_CR16
  publication-title: Nucl Med Biol
  doi: 10.1016/S0969-8051(02)00411-0
– volume: 2
  start-page: 4
  year: 2009
  ident: BFnpp2017148_CR13
  publication-title: Ment Health Phys Act
  doi: 10.1016/j.mhpa.2009.01.002
– volume: 40
  start-page: 123
  year: 1996
  ident: BFnpp2017148_CR51
  publication-title: J Psychosom Res
  doi: 10.1016/0022-3999(95)00554-4
– volume: 54
  start-page: 1063
  year: 1988
  ident: BFnpp2017148_CR49
  publication-title: J Pers Soc Psychol
  doi: 10.1037/0022-3514.54.6.1063
– volume: 99
  start-page: 7084
  year: 2002
  ident: BFnpp2017148_CR30
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.102174799
– volume: 45
  start-page: 1469
  year: 2015
  ident: BFnpp2017148_CR34
  publication-title: Sports Med
  doi: 10.1007/s40279-015-0365-0
– volume: 35
  start-page: 4
  year: 2010
  ident: BFnpp2017148_CR21
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2009.129
– volume: 39
  start-page: 1417
  year: 2007
  ident: BFnpp2017148_CR28
  publication-title: Med Sci Sports Exerc
  doi: 10.1249/mss.0b013e31806ad73c
– volume: 131
  start-page: 1171
  year: 2008
  ident: BFnpp2017148_CR24
  publication-title: Brain
  doi: 10.1093/brain/awm255
– volume: 9
  start-page: 398
  year: 1989
  ident: BFnpp2017148_CR17
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1038/jcbfm.1989.59
– volume: 36
  start-page: 275
  year: 2009
  ident: BFnpp2017148_CR25
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-008-0935-6
– volume: 72
  start-page: 371
  year: 2012
  ident: BFnpp2017148_CR8
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2012.01.027
– volume: 17
  start-page: 94
  year: 1985
  ident: BFnpp2017148_CR35
  publication-title: Med Sci Sports Exerc
– volume: 97
  start-page: 171
  year: 2015
  ident: BFnpp2017148_CR39
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2015.05.022
– volume: 29
  start-page: 547
  year: 2011
  ident: BFnpp2017148_CR4
  publication-title: J Sports Sci
  doi: 10.1080/02640414.2010.545427
– volume: 22
  start-page: 5100
  year: 2002
  ident: BFnpp2017148_CR52
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-12-05100.2002
SSID ssj0015768
Score 2.529427
Snippet Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 246
SubjectTerms Affect - physiology
Analgesics, Opioid - metabolism
Cerebral Cortex - diagnostic imaging
Cerebral Cortex - metabolism
Cortex (cingulate)
Emotions
Exercise
Exercise - physiology
Fentanyl - analogs & derivatives
Fentanyl - metabolism
Gyrus Cinguli - diagnostic imaging
Gyrus Cinguli - metabolism
Healthy Volunteers
High-Intensity Interval Training
Hippocampus - diagnostic imaging
Hippocampus - metabolism
Human subjects
Humans
Interval training
Male
Mood
Narcotics
Opioid receptors
Original
Pain
Physical training
Positron emission tomography
Positron-Emission Tomography - methods
Prefrontal Cortex - diagnostic imaging
Prefrontal Cortex - metabolism
Receptors, Opioid, mu - metabolism
Reinforcement
Thalamus
Thalamus - diagnostic imaging
Thalamus - metabolism
Young Adult
Title Opioid Release after High-Intensity Interval Training in Healthy Human Subjects
URI https://www.ncbi.nlm.nih.gov/pubmed/28722022
https://www.proquest.com/docview/1975586539
https://www.proquest.com/docview/1920394434
https://pubmed.ncbi.nlm.nih.gov/PMC5729560
Volume 43
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_BJiFeEHR8dIzJSLAXFi2xHTt5Qi1aNSGtm6ZO6lsU24moBGlZu4f899w5bkZB8JSHXD7P9v3uw78D-GBsomqt0U3VwkVSGYdTiusoNrVyzjrEDLQb-XKqLm7l13k6DwG3dSir3K6JfqF2S0sx8rMk12maEZHq59XPiLpGUXY1tNB4DPtEXUYlXXreO1wJYWmPInMRoS82D4XvscjOmhWRVSYaV4ps1yT9hTP_LJf8zf5MnsOzABzZqNP0C3hUNQM4GDXoNP9o2QnzpZw-Rj6AJ5chYz6Ak-uOm7o9ZbOHrVbrU39Fz1rdHsDV1WqxXDh2g3YILRvzzcMZlYFEocx90zIfP8SxyWahswRbNKzbydQynw9guBJRaGf9Em4n57MvF1HothBZmfBNpExei7JSaM-VS5XNlY15lUmjhIvTupKlQ7SFvnTN0cvKuEbwZk0tS2Pj0nArXsFes2yqN8CstaKyTlsXlzJXdc4N3saKxBopuMuG8Gn7wwsbqMipI8b3wqfERVagegpSD3omKP2xl151FBz_kDva6q4IE3FdPAybIbzvT-MUorxI2VTLe5LhMe0PFnIIrztV9w_CT-Uccc4Q9M4g6AWInnv3TLP45mm6U_RbEE8e_v-13sJT_ICsi-ocwd7m7r56hzhnY479YD6G_dFkPJ7icXw-vb75BVscAaw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeJuj46BhgJLYXFi2xHSd5mNCATR1bu2nqpL5lsZ2ISltaaCeUf4q_cWfHySgI3vacS5r07ny_-wZ4L1UgiihCNzVi2uNCalQpGnm-LITWSiNmMN3Ig6HoX_Cv43C8Ar-aXhhTVtmcifag1lNlYuS7QRKFYWwGqX6cfffM1iiTXW1WaNRicZxXP9Flm-8dfUH-blF6eDD63PfcVgFP8YAuPCGTgmW5QLsldChUIpRP85hLwbQfFjnPNKIK9BkLit5ETCMEKUoWPJPKzyRVDJ_7AFY5Q1emA6ufDoZn523ewqB3i1sT5qH3N3al9j6Ld8uZGY8ZRHg2xctG8C9k-2eB5m8W7_AJrDmoSvZr2XoKK3nZhfX9Et3064psE1s8aqPyXXg4cDn6Lmyf1dOwqx0yumvumu_YO9o52dU6nJ7OJtOJJudo-dCWEruunJjCE88V1i8qYiOWqA1k5HZZkElJ6t6pitgMBMGzzwST5s_g4l448Rw65bTMXwJRSrFc6UhpP-OJKBIq8TGKBUpyRnXcgw_NH54qN_zc7OC4Sm0SnsUpsic17EFfCKm3WupZPfTjH3SbDe9Sp_rz9E5Qe_CuvYxKazIxWZlPbwwN9U1HMuM9eFGzuv0h_FRKEVn1IFoSgpbADARfvlJOvtnB4CF6SohgN_7_Wm_hUX80OElPjobHr-Axfkxcx5Q2obP4cZO_RpS1kG-caBO4vG9tugUM5TyN
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4aQ5p4QdBx6RhgJLYXFjWxHTt5QGhiVBtjF6FO6lsW24moxNJu7TTlr-3Xcew4GQXB255zkiY9t-_43ADeKx2JUkoMUyUzARfKoEpRGYSqFMZog5jBdiMfHYv9M_51HI9X4LbthbFlla1NdIbaTLU9Ix9EqYzjxA5SHZS-LOJ0b_hpdhnYDVI209qu02hE5LCobzB8m3882ENeb1E6_DL6vB_4DQOB5hFdBEKlJcsLgT5MmFjoVOiQFglXgpkwLgueG0QYGD-WFCOLhEoELFqVPFc6zBXVDJ_7AB5KFkdWx-S4C_Yii-Mdgk1ZgHHg2BfdhywZVDM7KDOSaKWSZXf4F8b9s1TzN983fAKPPWglu42UPYWVourB-m6FAftFTbaJKyN15_M9WDvy2foebJ82c7HrHTK6a_Oa77g7uonZ9TqcnMwm04kh39EHolclbnE5sSUogS-xX9TEnV2iXpCR32pBJhVpuqhq4nIRBK2gPVaaP4Oze-HDc1itplXxEojWmhXaSG3CnKeiTKnCx2gWacUZNUkfPrR_eKb9GHS7jeNn5tLxLMmQPZllD0ZFSL3VUc-a8R__oNtseZd5IzDP7kS2D--6y6i-NieTV8X02tLQ0PYmM96HFw2rux_CT6UUMVYf5JIQdAR2NPjylWryw40IjzFmQiy78f_XegtrqEPZt4Pjw1fwCL8laQ6XNmF1cXVdvEa4tVBvnFwTOL9vRfoFM1U_XQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Opioid+Release+after+High-Intensity+Interval+Training+in+Healthy+Human+Subjects&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Saanijoki%2C+Tiina&rft.au=Tuominen%2C+Lauri&rft.au=Tuulari%2C+Jetro+J&rft.au=Nummenmaa%2C+Lauri&rft.date=2018-01-01&rft.pub=Nature+Publishing+Group&rft.issn=0893-133X&rft.eissn=1740-634X&rft.volume=43&rft.issue=2&rft.spage=246&rft.epage=254&rft_id=info:doi/10.1038%2Fnpp.2017.148&rft_id=info%3Apmid%2F28722022&rft.externalDocID=PMC5729560
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon